DCM
REGN icon

Dupont Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Dupont Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-631
Closed -$518K – 692
2023
Q1 		$518K Sell
631
-631
-50% -$476K 0.02% 316
2022
Q4 		$911K Sell
1,262
-575
-31% -$424K 0.04% 398
2022
Q3 		$1.26M Buy
1,837
+95
+5% +$59.8K 0.08% 294
2022
Q2 		$1.03M Sell
1,742
-10
-0.6% -$6.5K 0.05% 409
2022
Q1 		$1.22M Sell
1,752
-1,680
-49% -$1.06M 0.05% 406
2021
Q4 		$2.17M Sell
3,432
-609
-15% -$374K 0.08% 239
2021
Q3 		$2.45M Sell
4,041
-1,002
-20% -$622K 0.08% 265
2021
Q2 		$2.82M Buy
5,043
+1,350
+37% +$684K 0.07% 263
2021
Q1 		$1.75M Sell
3,693
-1,080
-23% -$526K 0.04% 392
2020
Q4 		$2.31M Sell
4,773
-325
-6% -$175K 0.05% 299
2020
Q3 		$2.85M Buy
5,098
+280
+6% +$170K 0.06% 239
2020
Q2 		$3M Buy
4,818
+933
+24% +$530K 0.07% 226
2020
Q1 		$1.9M Buy
3,885
+818
+27% +$337K 0.05% 307
2019
Q4 		$1.15M Buy
3,067
+1,756
+134% +$591K 0.03% 531
2019
Q3 		$364K Hold
1,311
– – 0.01% 914
2019
Q2 		$410K Hold
1,311
– – 0.01% 870
2019
Q1 		$538K Hold
1,311
– – 0.01% 733
2018
Q4 		$490K Buy
1,311
+345
+36% +$126K 0.01% 739
2018
Q3 		$390K Buy
+966
New +$368K 0.01% 758
2018
Q1 		– Sell
-481
Closed -$181K – 1005
2017
Q4 		$181K Buy
481
+94
+24% +$38.1K ﹤0.01% 794
2017
Q3 		$173K Sell
387
-60
-13% -$28.6K ﹤0.01% 819
2017
Q2 		$220K Buy
+447
New +$196K ﹤0.01% 807

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dupont Capital Management's REGN Position: Q2 2023 in Review

Dupont Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2023, closing a stake of 631 shares — an estimated $518K sold.

Dupont Capital Management first reported a position in REGN in Q2 2017 and held it in 22 quarters. The position peaked at $3M in Q2 2020. 1,164 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

  • Dupont Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Dupont Capital Management sold 631 Regeneron Pharmaceuticals shares in Q2 2023, an estimated $518K.
  • Dupont Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2017 and held it in 22 quarters.
  • Dupont Capital Management's Regeneron Pharmaceuticals position peaked at $3M in Q2 2020.
  • 1,164 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on Dupont Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.